Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

Clinical Infectious Diseases

Volumn 26, Issue 6, 1998, Pages 1418-1424

  Englund, Janet A ^a   Champlin, Richard E ^b   Wyde, Philip R ^b   Kantarjian, Hagop ^b   Atmar, Robert L ^b   Tarrand, Jeffrey ^b   Yousuf, Hassan ^b   Regnery, Helen ^b   Klimov, Alexander I ^b   Cox, Nancy J ^b   Whimbey, Estella ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; RIMANTADINE;

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; INFLUENZA; INFLUENZA VIRUS A; LEUKEMIA; PRIORITY JOURNAL;

EID: 17344373547     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516358     Document Type: Article

References (27)

1. Kempe A, Flail CB, Macdonald NE, et al. Influenza in children with cancer. J Pediatr 1989; 115:33-9.
2. Hirschhorn LR, McIntosh K, Anderson KG, Dermody TS. Influenzal pneumonia as a complication of autologous bone marrow transplantation. Clin Infect Dis 1992; 14:786-7.
3. Ljungman P, Andersson J, Aschan J, et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993; 17:244-7.
4. Whimbey E, Elting LS, Couch RB, et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994; 13:437-40.
5. Elting LS, Whimbey E, Lo W, et al. Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Support Care Cancer 1995;3:198-202.
6. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22:778-82.
7. Yousuf H, Englund JA, Couch RB, et al. Influenza among hospitalized adult patients with leukemia. Clin Infect Dis 1997; 24:1095-9.
8. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 1997; 102(suppl 3A):10-18.
9. Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982;307:580-4.
10. Van Voris LP, Betts RF, Handen FG, Christmas WF, Douglas RG Jr. Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 1981;245:1128-31.
11. Hall CB, Dolin R, Gala CL, et al. Children with influenza A infection: treatment with rimantadine. Pediatr 1987:80:275-82.
12. Clover RD, Crawford SA, Abell TD, Ramsey CN, Glezen WP, Couch RB. Effectiveness of rimantadine prophylaxis of children within families. AJDC 1986; 140:706-9.
13. Patriarca PA, Arden NH, Koplan JP, Goodman RA. Prevention and control of type A influenza infections in nursing homes. Ann Intern Med 1987; 107:732-40.
14. Centers for Disease Control and Prevention. Prevention and control of influenza. MMWR 1996;41:9-13.
15. Low W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G. Influenza vaccination in adult lyphoma patients during chemotherapy: antibody response to a two-dose vaccine regimen. Eur J Clin Microbiol Infect Dis 1993; 12:778-81.
16. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. The molecular basis of the specific anti-influenza action of amantadine. EMBO J 1985;4: 3021-4.
17. Belshe RB, Burk B, Newman F, Cerruti RL, Sim IS. Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 1989; 159:430-8.
18. Thompson J, Fleet W, Lawrence E, Pierce E, Morris L, Wright P. A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children. J Med Virol 1987;21:249-55.
19. Hayden FG, Couch RB. Clinical and epidemiological importance of influenza A viruses resistant to amantadine and rimantadine. Rev Med Virol 1992;2:89-96.
20. Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989;321:1696-702.
21. Degelau J, Somani SK, Cooper SL, Guay DR, Crossley KB. Amantadine-resistant influenza A in a nursing facility. Arch Intern Med 1992; 152: 390-2.
22. Houck P, Hemphil M, LaCroix S, Hirsh D, Cox N. Amantadine-resistant influenza A in nursing homes. Arch Intern Med 1995; 155:533-7.
23. Mast EEL, Harmon MW, Gravenstein S, et al. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol 1991; 134:988-97.
24. Klimov AI, Rocha E, Hayden FG, Shult PA, Foumillat LF, Cox NJ. Prolonged shedding of amantadine-resistant influenza A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172:1352-5.
25. Hayden FG, Sable CA, Connor JD, Lane J. Intravenous ribavirin by constant infusion for serious influenza and parainfluenza virus infection. Antiviral Therapy 1996; 1:51-6.
26. Rocha E, Cox NJ, Black RA, Harmon MW, Harrison CJ, Kendal AP. Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunocompromised child. J Virol 1991; 65:2340-50.
27. Prichard MN, Prichard LE, Baguley WA, Nassiri MR, Shipman C Jr. Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine. Antimicrob Agents Chemother 1990;35:1060-5.